Morphological and functional abnormalities in neuromuscular junctions of Drosophila melanogaster induced by human APP gene expression

[1]  M. Vitek,et al.  Apolipoprotein E-Mimetics Inhibit Neurodegeneration and Restore Cognitive Functions in a Transgenic Drosophila Model of Alzheimer's Disease , 2009, PloS one.

[2]  L. Guyant‐Maréchal.  APP locus duplication causes Alzheimer disease with cerebral amyloid angiopathy , 2009, Journal of Neurological Sciences.

[3]  S. Rohn,et al.  FAD-mutation of APP is associated with a loss of its synaptotrophic activity , 2009, Neurobiology of Disease.

[4]  P. Verstreken,et al.  FM 1-43 labeling of synaptic vesicle pools at the Drosophila neuromuscular junction. , 2008, Methods in molecular biology.

[5]  H. Anandatheerthavarada,et al.  Amyloid Precursor Protein and Mitochondrial Dysfunction in Alzheimer's Disease , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[6]  K. Beyreuther,et al.  Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity , 2007, The European journal of neuroscience.

[7]  J. Ting,et al.  Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms , 2007, Proceedings of the National Academy of Sciences.

[8]  Y. Larmet,et al.  Unraveling in vivo Functions of Amyloid Precursor Protein: Insights from Knockout and Knockdown Studies , 2006, Neurodegenerative Diseases.

[9]  V. Budnik,et al.  The fly neuromuscular junction : structure and function , 2006 .

[10]  Bassem A. Hassan,et al.  Amyloid precursor protein promotes post‐developmental neurite arborization in the Drosophila brain , 2005, The EMBO journal.

[11]  P. Hollenbeck.  Mitochondria and Neurotransmission: Evacuating the Synapse , 2005, Neuron.

[12]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[13]  Dominic M. Walsh,et al.  Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.

[14]  Nancy M Bonini,et al.  Human neurodegenerative disease modeling using Drosophila. , 2003, Annual review of neuroscience.

[15]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[16]  Kendal Broadie,et al.  Living synaptic vesicle marker: Synaptotagmin‐GFP , 2002, Genesis.

[17]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[18]  B. de Strooper,et al.  A cell biological perspective on Alzheimer's disease. , 2002, Annual review of cell and developmental biology.

[19]  L. Goldstein,et al.  Disruption of Axonal Transport and Neuronal Viability by Amyloid Precursor Protein Mutations in Drosophila , 2001, Neuron.

[20]  D. Selkoe.  Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. , 2001, Journal of Alzheimer's disease : JAD.

[21]  S. Tomita,et al.  Overexpression of human amyloid precursor protein in Drosophila. , 2000, Molecular cell biology research communications : MCBRC.

[22]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[23]  G. Matthews,et al.  The Role of Mitochondria in Presynaptic Calcium Handling at a Ribbon Synapse , 2000, Neuron.

[24]  V. Budnik,et al.  The Drosophila β-Amyloid Precursor Protein Homolog Promotes Synapse Differentiation at the Neuromuscular Junction , 1999, The Journal of Neuroscience.

[25]  K. White,et al.  Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport , 1999, Current Biology.

[26]  G. Collingridge,et al.  Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein , 1999, Neuropharmacology.

[27]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[28]  Y. Kidokoro,et al.  Two Distinct Pools of Synaptic Vesicles in Single Presynaptic Boutons in a Temperature-Sensitive Drosophila Mutant, shibire , 1998, Neuron.

[29]  E. Masliah,et al.  Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  E. Masliah,et al.  Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.

[31]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.